Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UCB has signed a research pact focus on the Central Nervous System (CNS) and immunology with Harvard University, under which UCB will offer $6m to fund specific research projects led by Harvard scientists.
Subscribe to our email newsletter
The collaboration is expected to enhance the drug development projects and the ongoing Harvard research projects by creating a drug discovery bridge between academia and industry.
Under Harvard-UCB collaboration, the first research project funded for Gokhan Hotamisligil, Department of Genetics and Complex Diseases, chair, Harvard School of Public Health, for the creation of development of antibodies against a target with potential application in a range of diseases including diabetes and metabolic disorders.
UCB NewMedicines president Ismail Kola said the aim of our alliance with Harvard is to create a two-way exchange of knowledge and expertise that will facilitate the successful development of innovative new drugs.